ES2053582T3 - Procedimiento para la obtencion de derivados del acido 5-amino-4-hidroxivalerianico. - Google Patents

Procedimiento para la obtencion de derivados del acido 5-amino-4-hidroxivalerianico.

Info

Publication number
ES2053582T3
ES2053582T3 ES87810450T ES87810450T ES2053582T3 ES 2053582 T3 ES2053582 T3 ES 2053582T3 ES 87810450 T ES87810450 T ES 87810450T ES 87810450 T ES87810450 T ES 87810450T ES 2053582 T3 ES2053582 T3 ES 2053582T3
Authority
ES
Spain
Prior art keywords
alkyl
acid
amino
eventually
rest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87810450T
Other languages
English (en)
Inventor
Peter Dr Herold
Christof Dr Angst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2053582T3 publication Critical patent/ES2053582T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/26—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS PROCEDIMIENTOS Y PRODUCTOS INTERMEDIOS PARA LA PREPARACION DE NUEVOS DERIVADOS DEL ACIDO 5-AMINO-4-HIDROXI-VALERIANICO DE FORMULA (I) EN LA QUE R1 ES H, EVENTUALMENTE ALQUILO SUSTITUIDO, CICLOALQUILO, CICLOALQUILO ALQUILO INFERIOR, ARILO, ARILALQUILO INFERIOR O EL RESTO DE UN AMINOACIDO NATURAL; R2 HIDROGENO, EVENTUALMENTE ALQUILO SUSTITUIDO, CICLOALQUILO-ALQUILO-INFERIOR, ARILO, ARILALQUILO (INFERIOR), AMINO, HIDROXI, MERCAPTO SULFINILO, SULFONILO O EL RESTO DE UN AMINOACIDO NATURAL Y R3 ES EVENTUALMENTE HIDROXI AMINO SUSTITUIDO. MEDIANTE TRANSPOSICION SIGMATROPICA DEL ESTER ALILICO ADECUADO, HALOLACTONIZACION DEL ACIDO GAMMA, DELTA- NO SATURADO OBTENIDO O DE UN DERIVADO ADECUADO, INTERCAMBIO DE HALOGENO MEDIANTE UN NUCLEOFILO QUE CONTENGA NITROGENO, APERTURA DEL ANILLO LACTONA Y LIBERACION DEL GRUPO AMINO. LOS COMPUESTOS DE LA FORMULA (I) SON MATERIALES DE PARTIDA PARA LA OBTENCION DE INHIBIDORES DE RENINA CON ACTIVIDAD ANTI-HIPERTENSORA.
ES87810450T 1986-08-13 1987-08-07 Procedimiento para la obtencion de derivados del acido 5-amino-4-hidroxivalerianico. Expired - Lifetime ES2053582T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH324886 1986-08-13

Publications (1)

Publication Number Publication Date
ES2053582T3 true ES2053582T3 (es) 1994-08-01

Family

ID=4251859

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87810450T Expired - Lifetime ES2053582T3 (es) 1986-08-13 1987-08-07 Procedimiento para la obtencion de derivados del acido 5-amino-4-hidroxivalerianico.

Country Status (14)

Country Link
US (2) US4898977A (es)
EP (1) EP0258183B1 (es)
JP (1) JP2571230B2 (es)
KR (1) KR950013635B1 (es)
AT (1) ATE86971T1 (es)
DD (1) DD269148A5 (es)
DE (1) DE3784812D1 (es)
DK (1) DK420887A (es)
ES (1) ES2053582T3 (es)
FI (1) FI90762C (es)
HU (3) HU200981B (es)
IL (1) IL83497A (es)
MX (1) MX7727A (es)
PT (1) PT85520B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992562A (en) * 1985-08-09 1991-02-12 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
US5076973A (en) * 1988-10-24 1991-12-31 Arizona Board Of Regents Synthesis of dolastatin 3
AU629867B2 (en) * 1988-11-17 1992-10-15 Imperial Chemical Industries Plc Triazolo (4,3a) pyrazine derivatives
GB8912659D0 (en) * 1989-06-02 1989-07-19 Ici Plc Process
GB8927915D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Novel alcohols
DE4008403A1 (de) * 1990-03-16 1991-09-19 Merck Patent Gmbh Glykolsaeurederivate
US5436339A (en) * 1991-03-06 1995-07-25 Abbott Laboratories Process for the preparation of a substituted diaminoalcohol
EP0546230A1 (en) * 1991-12-10 1993-06-16 Merrell Dow Pharmaceuticals Inc. Novel process for preparing 4-amino-5-hexenoic acid
US5294737A (en) * 1992-02-27 1994-03-15 The Research Foundation State University Of New York Process for the production of chiral hydroxy-β-lactams and hydroxyamino acids derived therefrom
US5977278A (en) * 1993-11-03 1999-11-02 E. I. Du Pont De Nemours And Company Polymers formed from allylic chain transfer agents
IL111484A (en) * 1993-11-03 2001-06-14 Commw Scient Ind Res Org Polymerization process using pendant chain transfer means to regulate the molecular weight, the polymers thus obtained and a number of new pesticide compounds
AU688403B2 (en) * 1993-11-03 1998-03-12 Commonwealth Scientific And Industrial Research Organisation Allylic chain transfer agents
US5475138A (en) * 1994-07-07 1995-12-12 Pharm-Eco Laboratories Incorporated Method preparing amino acid-derived diaminopropanols
US5473104A (en) * 1994-09-13 1995-12-05 Neurocrine Biosciences, Inc. Process for the preparation of L-carnitine
US5760019A (en) * 1996-07-12 1998-06-02 The Research Foundation Of State University Of New York Silanol enzyme inhibitors
US6423850B1 (en) 1999-06-18 2002-07-23 E.I. Du Pont De Nemours And Company Preparation and use of gamma-butyrolactones as cross-linking agents
US6833460B2 (en) * 1999-06-18 2004-12-21 E. I. Du Pont De Nemours And Company Preparation and use of gamma-butyrolactones as cross-linking agents
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) * 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
EP1511477A4 (en) * 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
JP2006508986A (ja) * 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
CN101160281A (zh) * 2005-04-06 2008-04-09 特瓦制药工业有限公司 结晶形态的普瑞巴林
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
MX2007012606A (es) * 2005-04-11 2008-01-11 Teva Pharma Proceso para elaborar (s)-pregabalina.
WO2006122258A1 (en) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Method for the preparation of pregabalin and salts thereof
MX2007000525A (es) * 2005-05-10 2007-03-28 Teva Pharma Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella.
ES2372700T3 (es) * 2005-05-10 2012-01-25 Teva Pharmaceutical Industries Ltd Resolución óptica del ácido 3-carbamoilmetil-5-metil hexanoico.
WO2007035789A1 (en) * 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the new synthesis of (s)-pregabalin
WO2007139933A2 (en) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
WO2007143113A2 (en) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. The use of enzymatic resolution for the preparation of intermediates of pregabalin
WO2007143152A2 (en) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. Preparation of (s)-pregabalin-nitrile
TW200846308A (en) * 2007-03-22 2008-12-01 Teva Pharma Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
WO2009158343A1 (en) * 2008-06-23 2009-12-30 Teva Pharmaceutical Industries, Ltd. Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester
US8257462B2 (en) * 2009-10-15 2012-09-04 Federal-Mogul Corporation Iron-based sintered powder metal for wear resistant applications
JP5585172B2 (ja) * 2010-04-05 2014-09-10 三菱瓦斯化学株式会社 脂環式エステル化合物の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB960005A (en) * 1961-01-18 1964-06-10 Distillers Co Yeast Ltd Production of acrylic and methacrylic esters
DE1914380A1 (de) * 1969-03-21 1970-10-01 Basf Ag Verfahren zur Herstellung von Buta-1,3-dien-1-carbonsaeurealkylestern
US4031115A (en) * 1976-03-29 1977-06-21 Chevron Research Company 4-Pentenoic acid conversion
CH634815A5 (fr) * 1978-08-30 1983-02-28 Firmenich & Cie Procede pour la preparation d'esters et acides gamma, delta-insatures.
US4372974A (en) * 1980-06-25 1983-02-08 New York University Anticonvulsive compositions and method of treating convulsive disorders
US4609643A (en) * 1980-08-06 1986-09-02 Aktiebolaget Hassle Renin inhibitors, treatments and dipeptide synthesis
US4487963A (en) * 1983-01-03 1984-12-11 Merck & Co., Inc. Enantioselective synthesis of 4-amino-3-hydroxy-2,4-(disubstituted)pentanoic acid
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
DK356085A (da) * 1984-08-06 1986-02-07 Upjohn Co Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
US4665055A (en) * 1985-06-17 1987-05-12 Merck & Co., Inc. Peptide renin inhibitors
HU204285B (en) * 1986-10-31 1991-12-30 Pfizer Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI873467A0 (fi) 1987-08-10
HU200981B (en) 1990-09-28
MX7727A (es) 1993-12-01
US4898977A (en) 1990-02-06
EP0258183A3 (en) 1989-07-26
HU198445B (en) 1989-10-30
ATE86971T1 (de) 1993-04-15
JP2571230B2 (ja) 1997-01-16
EP0258183A2 (de) 1988-03-02
KR880002808A (ko) 1988-05-11
DD269148A5 (de) 1989-06-21
FI873467A7 (fi) 1988-02-14
KR950013635B1 (ko) 1995-11-13
FI90762B (fi) 1993-12-15
DK420887A (da) 1988-02-14
EP0258183B1 (de) 1993-03-17
DE3784812D1 (de) 1993-04-22
IL83497A0 (en) 1988-01-31
HU202218B (en) 1991-02-28
US5010189A (en) 1991-04-23
PT85520B (pt) 1990-06-29
HUT44478A (en) 1988-03-28
DK420887D0 (da) 1987-08-12
PT85520A (en) 1987-09-01
IL83497A (en) 1993-02-21
JPS6357561A (ja) 1988-03-12
FI90762C (fi) 1994-03-25

Similar Documents

Publication Publication Date Title
ES2033840T3 (es) P-aminoetilsulfonanilidas n-sustituidas como agentes antiarritmicos; e intermedios para los mismos.
ES8104275A1 (es) Un metodo para la preparacion de derivados de ftalimidina
ES2221440T3 (es) Derivados de acido aminofenoxiacetico como neuroprotectores.
FI834872A0 (fi) Substituerade 4-aminoetylen-kromaner och -kromener, foerfaranden foer deras framstaellning och deraanvaendning som laekemedel
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
ES2059724T3 (es) Un procedimiento para preparar derivados de purinil piperacina 6-sustituidos.
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES8303329A1 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaal- canoil o azaaralcanoil)-indolin-2-carboxilicos.
ES8705408A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
ES484327A1 (es) Procedimiento para la obtencion de 2-imino-1,3-tiaza-ciclo- alcanos
MX9304399A (es) Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
ES2037257T3 (es) Procedimiento de obtencion de los derivados de n-aminobutil y n-fenil arilamidas.
ES8604196A1 (es) Procedimiento para la preparacion de n-piridilindoles
ES8405783A1 (es) Procedimiento para la obtencion de derivados de n-oxidos de la piridina.
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
ES8203343A1 (es) Un procedimiento de preparacion de tetra hidrobenzoindoles.
ES2028042T3 (es) Procedimiento para la obtencion de derivados de 1,8-naftiridina y fungidas que les contienen.
ES8705394A1 (es) Procedimiento para la obtencion de imidazoles sustituidos
ES469353A1 (es) Un procedimiento para la preparacion de compuestos derivadosde bencimidazol
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
ES2028873T3 (es) Metodo para preparar derivados de tiazolidin-4-ona y sus sales por adicion de acidos.
ES2038218T3 (es) Un procedimiento para preparar nuevos derivados de 2-alquilsulfinil-4(3h)-quinazolinona.
AR240813A2 (es) N-fenilsulfonil-n'-pirimidinilureas, procedimiento para su preparacion, composiciones que las contienen e intermediarios para uso exclusivo en dicho procedimiento
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 258183

Country of ref document: ES